Skip to main content

Advertisement

SpringerLink
Log in

Expression of nuclear factor κB in human gastric carcinoma: relationship with IκBa and prognostic significance

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Nuclear factor (NF)-κB is a transcription factor constitutively activated in various neoplasms, including gastric carcinoma. However, its clinical significance in the latter remains an unresolved issue, as published information is limited and controversial. Furthermore, no data is available about the interaction of NFκB with its inhibitory protein IκBa in gastric carcinoma cases. In this study, the expression of NFκB1/p50 and pIκBa protein was evaluated immunohistochemically in paraffin-embedded tissues from 93 patients. The effect of NFκB1/p50 and pIκBa on clinical outcome was assessed. Positive immunostaining was detected for nuclear NFκB1/p50, cytoplasmic NFκB1/p50 and pIκBa in 91, 68 and 85.7% of cases, respectively. A positive correlation emerged between nuclear NFκB1/p50 and pIκBa (p < 0.0001) and a negative one between cytoplasmic NFκB1/p50 and pIκBa (p = 0.0033). Nuclear NFκB1/p50 was associated with stage (p = 0.0388), the depth of invasion (p = 0.0382), World Health Organization (WHO; p = 0.0326) and Lauren’s histological classification (p = 0.0046). NFκB1/p50 nuclear expression adversely affected survival in both univariate and multivariate analysis (p < 0.0001 and p = 0.02, respectively). Our results suggest that NFκB1/p50 nuclear expression and therefore activation is regulated by its interaction with IκBa and that the former may serve as a useful independent molecular marker for stratifying patients with gastric carcinoma in terms of prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Abdel-Latif MM, O’Riodan J, Windle HJ, Carton E, Ravi N, Kelleher D, Reynolds JV (2004) NF-κB activation in esophageal adenocarcinoma. Relationship to Barrett’s metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg 239:491–499

    Article  PubMed  Google Scholar 

  2. Baldwin AS (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14:649–683

    Article  PubMed  CAS  Google Scholar 

  3. Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K, Royer HD, Scheidereit C, Dorken B (1996) High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 87:4340–4347

    PubMed  CAS  Google Scholar 

  4. Bours V, Dejardin E, Goujon-Letawe F, Merville MP, Castronovo V (1994) The NF-κB transcription factor and cancer: high expression of NF-κB and IκB-related proteins in tumour cell lines. Biochem Pharmacol 47:145–149

    Article  PubMed  CAS  Google Scholar 

  5. Chen FE, Ghosh G (1999) Regulation of DNA binding by Rel/NFκB transcription factors: structural reviews. Oncogene 18:6845–6852

    Article  PubMed  CAS  Google Scholar 

  6. Dejardin E, Deregowski V, Chapelier M, Jacobs N, Gielen J, Merville MP, Bours V (1999) Regulation of NF kappa B activity by I kappaB-related proteins in adenocarcinoma cells. Oncogene 18:2567–2577

    Article  PubMed  CAS  Google Scholar 

  7. Dolcet X, Llobet D, Pallares J, Matias-Guiu X (2005) NF-kappaB in development and progression of human cancer. Virchows Arch 5:475–482

    Article  Google Scholar 

  8. Feinman R, Koury J, Thames M, Barlogie B, Epstein J, Siegel DS (1999) Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood 93:3044–3052

    PubMed  CAS  Google Scholar 

  9. Ghiorzo P, Mantelli M, Gargiulo S, Gramigni C, Pastorino L, Banelli B, Villaggio B, Coccia MC, Sementa AR, Garre C, Bianchi-Scarra G (2004) Inverse correlation between p16INK4A expression and NF-κB activation in melanoma progression. Hum Path 35:1029–1037

    Article  PubMed  CAS  Google Scholar 

  10. Ghosh S, May M, Kopp EB (1998) NFκB and Rel proteins: evolutionary conserved mediators of immune responses. Annu Rev Immunol 16:225–260

    Article  PubMed  CAS  Google Scholar 

  11. Gilmore TD (1999) The Rel/NFκB signal transduction pathway: introduction. Oncogene 18:6842–6844

    Article  PubMed  CAS  Google Scholar 

  12. Giri DK, Aggarwal BB (1998) Constitutive activation of NF-B causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumour necrosis factor and reactive oxygen intermediates. J Biol Chem 273:14008–14014

    Article  PubMed  CAS  Google Scholar 

  13. Hamilton SR, Aaltonen LA (2000) World Health Organization classification of tumours-pathology and genetics of the digestive system, pp 38, 43–46

  14. Horiguchi Y, Kuroda K, Nakashima J, Murai M, Umezawa K (2003) Antitumour effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells. Expert Rev Anticancer Ther 6:793–798

    Article  Google Scholar 

  15. Ito CY, Adey N, Bautch VL, Baldwin AS Jr (1995) Structure and elocution of the human IκBA gene. Genomics 29:490–495

    Article  PubMed  CAS  Google Scholar 

  16. Izzo JG, Malhotra U, Wu TT, Ensor J, Luthra R, Lee JH, Swisher SG, Liao Z, Chao KS, Hittelman WN, Aggarwal BB, Ajani JA (2006) Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma. J Clin Oncol 5:748–754

    Article  Google Scholar 

  17. Jackel MC (1998) Genetic control of programmed cell death (apoptosis). Prospects for biological tumour staging? HNO 46:614–625

    Article  PubMed  CAS  Google Scholar 

  18. Karin M (1999) How NFκB is activated: the role of IκB kinase (IKK) complex. Oncogene 18:6867–6874

    Article  PubMed  CAS  Google Scholar 

  19. Karin M, Cao Y, Greten FR, Li AW (2002) NFκB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301–310

    Article  PubMed  CAS  Google Scholar 

  20. Lee BL, Lee HS, Jung J, Cho SJ, Chung HY, Kim WH, Jin YW, Kim CS, Nam SY (2005) Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer. Clin Cancer Res 7:2518–2525

    Article  Google Scholar 

  21. Macri A, Versaci A, Loddo S, Scuderi G, Travagliante M, Trimarchi G, Teti D, Famulari C (2006) Serum levels of interleukin 1beta, interleukin 8 and tumour necrosis factor alpha as markers of gastric cancer. Biomarkers 2:184–193

    Article  Google Scholar 

  22. Mrena J, Wiksten JP, Nordling S, Kokkola A, Ristimaki A, Haglund C (2006) MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer. J Clin Pathol 59(6):618–623

    Article  PubMed  CAS  Google Scholar 

  23. Mukhopadhyay T, Roth JA, Maxwell SA (1995) Altered expression of the p50 subunit of the NF-kappaB transcription factor complex in non-small cell lung carcinoma. Oncogene 11:999–1003

    PubMed  CAS  Google Scholar 

  24. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Sledge GW (1997) Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17:3629–3639

    PubMed  CAS  Google Scholar 

  25. Orlowski JR, Baldwin AS (2002) NFκB as a therapeutic target in cancer. Trends Mol Med 8:385–389

    Article  Google Scholar 

  26. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533–543

    Article  PubMed  CAS  Google Scholar 

  27. Rayet B, Gelinas C (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18:6938–6947

    Article  PubMed  CAS  Google Scholar 

  28. Ross JS, Kallakury BV, Sheehan CE, Fisher HA, Kaufman RP Jr, Kaur P, Gray K, Stringer B (2004) Expression of nuclear factor-κB and IκB proteins in prostatic adenocarcinomas: correlation of nuclear factor-κB immunoreactivity with disease recurrence. Clin Cancer Res 10:2466–2472

    Article  PubMed  CAS  Google Scholar 

  29. Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, Nakamura K, Yamanaka T, Uchinaya A, Tabaka M, Katano M (2001) Nuclear factor-κB (RelA) trascription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 7:4136–4142

    PubMed  CAS  Google Scholar 

  30. Shattuck-Brandt RL, Richmond A (1997) Enhanced degradation of IκB contributes to endogenous activation of NF-B in Hs294T melanoma cells. Cancer Res 57:3032–3039

    PubMed  CAS  Google Scholar 

  31. Shibata W, Hirata Y, Yoshida H, Otsuka M, Hoshida Y, Ogura K, Maeda S, Ohmae T, Yanai A, Mitsuno Y, Seki N, Kawabe T, Omata M (2005) NF-kappaB and ERK-signaling pathways contribute to the gene expression induced by cag PAI-positive-Helicobacter pylori infection. World J Gastroenterol 39:6134–6143

    Google Scholar 

  32. Smith MG, Hold GL, Tahara E, El-Omar EM (2006) Cellular and molecular aspects of gastric cancer. World J Gastroenterol 12(19):2979–2990

    PubMed  CAS  Google Scholar 

  33. Tai DI, Tsai SL, Chang YH, Huang SN, Chen TC, Chang KS, Liaw YF (2000) Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 89(11):2274–2281

    Article  PubMed  CAS  Google Scholar 

  34. Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, Miano MP, Nigris F, Casalino L, Curcio F, Santoro M, Fusco A (1997) Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NF-κB p65 protein expression. Oncogene 15:1987–1994

    Article  PubMed  CAS  Google Scholar 

  35. Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ (1999) The nuclear factor-κB/RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 5:119–127

    PubMed  CAS  Google Scholar 

  36. Wang W, Luo HS, Yu BP (2004) Expression of NFκB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions. World J Gastroenterol 2:177–181

    Google Scholar 

  37. Wu CY, Wang CJ, Tseng CC, Chen HP, Wu MS, Lin JT, Inoue H, Chen GH (2005) Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathway. World J Gastroenterol 21:3197–3203

    Google Scholar 

  38. Yamanaka N, Sasaki N, Tasaki A, Nakashima H, Kubo M, Morisaki T, Noshiro H, Yao T, Tsuneyoshi M, Tanaka M, Katano M (2004) Nuclear factor-kappaB p65 is a prognostic indicator in gastric carcinoma. Anticancer Res 24:1071–1075

    PubMed  Google Scholar 

  39. Zhang J, Peng B, Chen X (2005) Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res 20:7334–7343

    Article  Google Scholar 

  40. Zhang PL, Pellitteri PK, Law A, Gilroy PA, Wood GC, Kennedy TL, Blasick TM, Lun M, Schuerch C 3rd, Brown RE (2005) Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis. Mod Pathol 7:924–932

    Article  Google Scholar 

  41. Zhang Z, Ma J, Li N, Sun N, Wang C (2006) Expression of nuclear factor-kappaB and its clinical significance in non small-cell lung cancer. Ann Thorac Surg 1:243–248

    Article  Google Scholar 

  42. Zhao XH, Gu SZ, Tian HG, Quan P, Pan BR (2005) Clinical significance of expression of apoptotic signal proteins in gastric carcinoma tissue. World J Gastroenterol 25:3846–3849

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, Athens, 11517, Greece

    Georgia Levidou, Penelope Korkolopoulou, Irene Thymara, Angelica A. Saetta & Efstratios Patsouris

  2. 2nd Propedeutic Department of Surgery, Medical School, National and Kapodistrian University of Athens, Athens, 11517, Greece

    Nikolaos Nikiteas, Nikolaos Tzanakis, Christos Tsigris, George Rallis & Konstantin Vlasis

Authors
  1. Georgia Levidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Penelope Korkolopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nikolaos Nikiteas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nikolaos Tzanakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Irene Thymara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Angelica A. Saetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Christos Tsigris
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. George Rallis
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Konstantin Vlasis
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Efstratios Patsouris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Georgia Levidou.

Additional information

G. Levidou, P. Korkolopoulou and N. Nikiteas have equally contributed to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levidou, G., Korkolopoulou, P., Nikiteas, N. et al. Expression of nuclear factor κB in human gastric carcinoma: relationship with IκBa and prognostic significance. Virchows Arch 450, 519–527 (2007). https://doi.org/10.1007/s00428-007-0396-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-007-0396-5

Keywords

Search

Navigation